PTC Therapeutics Inc

PTCTNASDAQ · US

Holders

REDUCEDT+2
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−691 sh · $50.4K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−2,390 sh · $171.8K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−5,335 sh · $388.7K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−7,165 sh · $527.8K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Schmertzler Michael
PTC Therapeutics Inc · NASDAQ
−9,419 sh · $666.7K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+7
Boulding Mark Elliott
PTC Therapeutics Inc · NASDAQ
−969 sh · $70.6K
Filed 19 Aug 2026SEC Form 4view source
ACQUIREDT+7
Boulding Mark Elliott
PTC Therapeutics Inc · NASDAQ
+2,813 sh · $72.3K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Boulding Mark Elliott
PTC Therapeutics Inc · NASDAQ
−1,844 sh · $133.5K
Filed 19 Aug 2026SEC Form 4view source
DISCLOSEDQuarterly
Polen Capital Management
PTC Therapeutics Inc · NASDAQ
24,916 sh · $2.0M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Two Sigma Investments
PTC Therapeutics Inc · NASDAQ
27,110 sh · $1.8M
Filed 31 Mar 2026SEC 13Fview source